FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056098081> ?p ?o ?g. }

• W2056098081 endingPage "413" @default.
• W2056098081 startingPage "407" @default.
• W2056098081 abstract "A longitudinal investigation has been conducted into the cell-mediated immune responses of onchocerciasis patients after a single-dose treatment with ivermectin. Untreated patients tested for delayed cutaneous hypersensitivity (DCH) to seven recall antigens showed lower responses than infection-free control individuals (P less than 0.01), but 6 and 14 months after treatment DCH reactions increased to similar levels to those seen in the controls. The in vitro cellular reactivity to Onchocerca volvulus-derived antigen (OvAg) was reduced in untreated patients as compared with controls, and the lymphocyte blastogenic responses to OvAg and streptolysin-O clearly improved up to 14 months after treatment. Peripheral blood mononuclear cells (PBMC) from untreated patients produced IL-1 beta, tumour necrosis factor-alpha (TNF-alpha) and IL-6 in response to mitogenic stimulation with phytohaemagglutinin (PHA), only low levels of IL-1 beta, IL-2 and TNF-alpha in response to OvAg, but higher amounts of IL-4 and interferon-gamma (IFN-gamma) in response to OvAg than control individuals. After ivermectin treatment, the OvAg-induced production of IL-1 beta and TNF-alpha increased significantly 1 and 14 months after treatment. The PHA-induced production of IL-2 and IL-4 increased 1 month after treatment and remained significantly elevated until 14 months after treatment, whereas the OvAg-specific secretion of IL-2, IL-4 and IFN-gamma did not change after ivermectin treatment. Flow cytometric analysis of lymphocyte-subsets in the peripheral blood of untreated patients revealed a relative and absolute (P less than 0.01) diminution of CD4+ cells and a significantly smaller CD4+/CD8+ cell ratio as compared with controls. By 4 weeks after treatment and thereafter, CD4+ T cells increased relatively and absolutely (P less than 0.01); likewise there was an absolute increase in T-helper-inducer cells (CD4+CD45RO+) and a temporarily improved CD4+/CD8+ cell ratio (P = 0.001). The expression of the low-affinity receptor for IgE (CD23) on total lymphocytes decreased from 14% to 7% by 14 months after treatment. The CD8+ cells and CD3+TCR gamma delta + cells were higher in patients than in controls and both remained elevated until 14 months after treatment. These results suggest a distinctly improved cellular immunity in human onchocerciasis that was facilitated by ivermectin therapy." @default.
• W2056098081 created "2016-06-24" @default.
• W2056098081 creator A5002860698 @default.
• W2056098081 creator A5009962101 @default.
• W2056098081 creator A5013511472 @default.
• W2056098081 creator A5017129520 @default.
• W2056098081 creator A5018478983 @default.
• W2056098081 creator A5023205592 @default.
• W2056098081 creator A5062079197 @default.
• W2056098081 creator A5082404751 @default.
• W2056098081 date "1992-09-01" @default.
• W2056098081 modified "2023-09-25" @default.
• W2056098081 title "Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment" @default.
• W2056098081 cites W1492381049 @default.
• W2056098081 cites W1528098311 @default.
• W2056098081 cites W153377523 @default.
• W2056098081 cites W1571491877 @default.
• W2056098081 cites W1572305746 @default.
• W2056098081 cites W1579394534 @default.
• W2056098081 cites W1617522153 @default.
• W2056098081 cites W1875076850 @default.
• W2056098081 cites W1942668068 @default.
• W2056098081 cites W1964502075 @default.
• W2056098081 cites W1966333025 @default.
• W2056098081 cites W1971303271 @default.
• W2056098081 cites W1977429862 @default.
• W2056098081 cites W1986393420 @default.
• W2056098081 cites W1990889809 @default.
• W2056098081 cites W1991994149 @default.
• W2056098081 cites W2020100658 @default.
• W2056098081 cites W2023171679 @default.
• W2056098081 cites W2030252570 @default.
• W2056098081 cites W2054978976 @default.
• W2056098081 cites W2060859400 @default.
• W2056098081 cites W2140202337 @default.
• W2056098081 cites W2172206393 @default.
• W2056098081 cites W2333413219 @default.
• W2056098081 cites W2401779147 @default.
• W2056098081 cites W2427974379 @default.
• W2056098081 cites W2474689416 @default.
• W2056098081 cites W344464588 @default.
• W2056098081 cites W4235204700 @default.
• W2056098081 cites W4238452015 @default.
• W2056098081 cites W43500759 @default.
• W2056098081 cites W79314742 @default.
• W2056098081 doi "https://doi.org/10.1111/j.1365-2249.1992.tb06971.x" @default.
• W2056098081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1554489" @default.
• W2056098081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1516257" @default.
• W2056098081 hasPublicationYear "1992" @default.
• W2056098081 type Work @default.
• W2056098081 sameAs 2056098081 @default.
• W2056098081 citedByCount "74" @default.
• W2056098081 countsByYear W20560980812012 @default.
• W2056098081 countsByYear W20560980812014 @default.
• W2056098081 countsByYear W20560980812016 @default.
• W2056098081 countsByYear W20560980812019 @default.
• W2056098081 countsByYear W20560980812021 @default.
• W2056098081 countsByYear W20560980812022 @default.
• W2056098081 countsByYear W20560980812023 @default.
• W2056098081 crossrefType "journal-article" @default.
• W2056098081 hasAuthorship W2056098081A5002860698 @default.
• W2056098081 hasAuthorship W2056098081A5009962101 @default.
• W2056098081 hasAuthorship W2056098081A5013511472 @default.
• W2056098081 hasAuthorship W2056098081A5017129520 @default.
• W2056098081 hasAuthorship W2056098081A5018478983 @default.
• W2056098081 hasAuthorship W2056098081A5023205592 @default.
• W2056098081 hasAuthorship W2056098081A5062079197 @default.
• W2056098081 hasAuthorship W2056098081A5082404751 @default.
• W2056098081 hasBestOaLocation W20560980811 @default.
• W2056098081 hasConcept C137061746 @default.
• W2056098081 hasConcept C147483822 @default.
• W2056098081 hasConcept C202751555 @default.
• W2056098081 hasConcept C203014093 @default.
• W2056098081 hasConcept C2777761686 @default.
• W2056098081 hasConcept C2777990475 @default.
• W2056098081 hasConcept C2778690821 @default.
• W2056098081 hasConcept C2780050583 @default.
• W2056098081 hasConcept C2780727990 @default.
• W2056098081 hasConcept C2780841837 @default.
• W2056098081 hasConcept C3017875465 @default.
• W2056098081 hasConcept C55493867 @default.
• W2056098081 hasConcept C71924100 @default.
• W2056098081 hasConcept C86803240 @default.
• W2056098081 hasConcept C8891405 @default.
• W2056098081 hasConceptScore W2056098081C137061746 @default.
• W2056098081 hasConceptScore W2056098081C147483822 @default.
• W2056098081 hasConceptScore W2056098081C202751555 @default.
• W2056098081 hasConceptScore W2056098081C203014093 @default.
• W2056098081 hasConceptScore W2056098081C2777761686 @default.
• W2056098081 hasConceptScore W2056098081C2777990475 @default.
• W2056098081 hasConceptScore W2056098081C2778690821 @default.
• W2056098081 hasConceptScore W2056098081C2780050583 @default.
• W2056098081 hasConceptScore W2056098081C2780727990 @default.
• W2056098081 hasConceptScore W2056098081C2780841837 @default.
• W2056098081 hasConceptScore W2056098081C3017875465 @default.
• W2056098081 hasConceptScore W2056098081C55493867 @default.
• W2056098081 hasConceptScore W2056098081C71924100 @default.
• W2056098081 hasConceptScore W2056098081C86803240 @default.

• next